$SLS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SELLAS Life Sciences Group, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in SELLAS Life Sciences Group, Inc.. Get notifications about new insider transactions in SELLAS Life Sciences Group, Inc. for free.

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 29 2011	GALE	Galena Biopharma, ...	Nisi Rudolph	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 29 2011	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 29 2011	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 29 2011	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Option Exercise	A	1.18	200,000	236,000	200,000
Mar 29 2011	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 29 2011	GALE	Galena Biopharma, ...	Chin Richard	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 29 2011	GALE	Galena Biopharma, ...	GALLIKER STEPHEN S	Director	Option Exercise	A	1.18	100,000	118,000	100,000
Mar 17 2011	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Grant	A	0.00	29,925	0	41,083	11.2 K to 41.1 K (+268.19 %)
Mar 17 2011	GALE	Galena Biopharma, ...	Tata Amy B	Principlw Acctg Off ...	Grant	A	0.00	14,065	0	14,065	0 to 14.1 K
Mar 17 2011	GALE	Galena Biopharma, ...	Pavco Pamela	VP of Pharmaceutica ...	Grant	A	0.00	33,563	0	44,940	11.4 K to 44.9 K (+295.01 %)
Mar 17 2011	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Science Offic ...	Grant	A	0.00	43,053	0	60,559	17.5 K to 60.6 K (+245.93 %)
Mar 17 2011	GALE	Galena Biopharma, ...	Beerman Noah D	CEO and President	Grant	A	0.00	77,587	0	92,994	15.4 K to 93 K (+503.58 %)
Jan 14 2011	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Jan 14 2011	GALE	Galena Biopharma, ...	GALLIKER STEPHEN S	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Jan 14 2011	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Jan 14 2011	GALE	Galena Biopharma, ...	Nisi Rudolph	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Jan 14 2011	GALE	Galena Biopharma, ...	Chin Richard	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Jan 14 2011	GALE	Galena Biopharma, ...	Ahn Mark J	Director	Option Exercise	A	2.31	50,000	115,500	50,000
Dec 30 2010	GALE	Galena Biopharma, ...	CYTRX CORP	10% Owner	Sell	S	2.20	2,593,881	5,706,538	0	2.6 M to 0 (-100.00 %)
Dec 23 2010	GALE	Galena Biopharma, ...	CYTRX CORP	10% Owner	Sell	S	2.65	500,000	1,325,000	2,593,881	3.1 M to 2.6 M (-16.16 %)
Jul 21 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Grant	A	2.04	5,600	11,424	11,158	5.6 K to 11.2 K (+100.76 %)
Jul 21 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Sell	S	2.05	5,000	10,266	5,558	10.6 K to 5.6 K (-47.36 %)
Jul 16 2010	GALE	Galena Biopharma, ...	Pavco Pamela	VP of Pharmaceutica ...	Grant	A	2.38	5,000	11,921	11,377	6.4 K to 11.4 K (+78.41 %)
Jul 14 2010	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Science Offic ...	Grant	A	2.23	10,000	22,300	17,506	7.5 K to 17.5 K (+133.23 %)
Jul 12 2010	GALE	Galena Biopharma, ...	Beerman Noah D	CEO and President	Buy	P	2.23	10,000	22,292	15,407	5.4 K to 15.4 K (+184.95 %)
Jul 12 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Grant	A	2.04	5,000	10,200	10,558	5.6 K to 10.6 K (+89.96 %)
Jul 02 2010	GALE	Galena Biopharma, ...	CYTRX CORP	10% Owner	Sell	S	2.55	2,000,000	5,100,000	3,093,881	5.1 M to 3.1 M (-39.26 %)
Jul 02 2010	GALE	Galena Biopharma, ...	CYTRX CORP	10% Owner	Sell	S	5.70	675,000	3,847,500	5,093,881	5.8 M to 5.1 M (-11.70 %)
Apr 16 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Option Exercise	A	4.41	15,000	66,150	15,000
Apr 16 2010	GALE	Galena Biopharma, ...	Pavco Pamela	VP of Pharmaceutica ...	Option Exercise	A	4.41	15,000	66,150	15,000
Apr 16 2010	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Science Offic ...	Option Exercise	A	4.41	15,000	66,150	15,000
Apr 16 2010	GALE	Galena Biopharma, ...	Andrikopoulos Konstantinos	VP, Legal	Option Exercise	A	4.41	15,000	66,150	15,000
Apr 02 2010	GALE	Galena Biopharma, ...	Samarsky Dmitry	VP, Technology Deve ...	Sell	S	4.65	4,081	18,977	0	4.1 K to 0 (-100.00 %)
Mar 30 2010	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Sell	S	5.66	25,000	141,500	6,000	31 K to 6 K (-80.65 %)
Mar 30 2010	GALE	Galena Biopharma, ...	GALLIKER STEPHEN S	Director	Sell	S	5.54	15,000	83,100	10,000	25 K to 10 K (-60.00 %)
Mar 04 2010	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Option Exercise	A	5.28	50,000	264,000	50,000
Jan 22 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Grant	A	0.00	5,558	0	5,558	0 to 5.6 K
Jan 22 2010	GALE	Galena Biopharma, ...	Samarsky Dmitry	VP, Technology Deve ...	Grant	A	0.00	4,081	0	4,081	0 to 4.1 K
Jan 22 2010	GALE	Galena Biopharma, ...	Pavco Pamela	VP of Pharmaceutica ...	Grant	A	0.00	6,377	0	6,377	0 to 6.4 K
Jan 22 2010	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Science Offic ...	Grant	A	0.00	7,506	0	7,506	0 to 7.5 K
Jan 22 2010	GALE	Galena Biopharma, ...	Andrikopoulos Konstantinos	VP, Legal	Grant	A	0.00	5,750	0	5,750	0 to 5.8 K
Jan 22 2010	GALE	Galena Biopharma, ...	Beerman Noah D	CEO and President	Grant	A	0.00	5,407	0	5,407	0 to 5.4 K
Jan 19 2010	GALE	Galena Biopharma, ...	Tata Amy B	Principle Acctg Off ...	Option Exercise	A	5.66	12,081	68,378	12,081
Jan 19 2010	GALE	Galena Biopharma, ...	Varanasi Ramani	VP Business Develop ...	Option Exercise	A	5.66	17,628	99,774	17,628
Jan 19 2010	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Science Offic ...	Option Exercise	A	5.66	27,182	153,850	27,182
Jan 19 2010	GALE	Galena Biopharma, ...	Pavco Pamela	VP of Pharmaceutica ...	Option Exercise	A	5.66	28,054	158,786	28,054
Jan 19 2010	GALE	Galena Biopharma, ...	Andrikopoulos Konstantinos	VP, Legal	Option Exercise	A	5.66	24,686	139,723	24,686
Jan 19 2010	GALE	Galena Biopharma, ...	Samarsky Dmitry	VP, Technology Deve ...	Option Exercise	A	5.66	18,121	102,565	18,121
Jan 19 2010	GALE	Galena Biopharma, ...	Nisi Rudolph	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Jan 19 2010	GALE	Galena Biopharma, ...	Beerman Noah D	CEO and President	Option Exercise	A	5.66	5,792	32,783	5,792
Jan 19 2010	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Jan 19 2010	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Jan 19 2010	GALE	Galena Biopharma, ...	GALLIKER STEPHEN S	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Jan 19 2010	GALE	Galena Biopharma, ...	Chin Richard	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Jan 19 2010	GALE	Galena Biopharma, ...	Ahn Mark J	Director	Option Exercise	A	5.66	50,000	283,000	50,000
Nov 09 2009	GALE	Galena Biopharma, ...	Beerman Noah D	CEO and President	Option Exercise	A	2.19	350,000	766,500	350,000
Oct 20 2009	GALE	Galena Biopharma, ...	Nisi Rudolph	Director	Grant	A	0.00	3,500	0	3,500	0 to 3.5 K
Oct 20 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Grant	A	0.00	5,000	0	5,000	0 to 5 K
Oct 20 2009	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Grant	A	0.00	25,000	0	31,000	6 K to 31 K (+416.67 %)
Oct 20 2009	GALE	Galena Biopharma, ...	GALLIKER STEPHEN S	Director	Grant	A	0.00	15,000	0	25,000	10 K to 25 K (+150.00 %)
Sep 25 2009	GALE	Galena Biopharma, ...	CYTRX CORP	10% Owner	Sell	S	2.50	500,000	1,250,000	5,768,881	6.3 M to 5.8 M (-7.98 %)
Sep 24 2009	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Scientific Of ...	Option Exercise	A	2.92	81,242	237,227	81,242
Sep 24 2009	GALE	Galena Biopharma, ...	Khvorova Anastasia	Chief Scientific Of ...	Option Exercise	A	2.92	18,758	54,773	18,758
Aug 20 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.13	8,990	28,157	0	9 K to 0 (-100.00 %)
Jul 06 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.19	1,723	7,214	8,988	10.7 K to 9 K (-16.09 %)
Jul 06 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.53	1,170	5,302	10,711	11.9 K to 10.7 K (-9.85 %)
Jul 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.45	2,900	12,896	11,881	14.8 K to 11.9 K (-19.62 %)
Jul 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.65	1,800	8,378	14,781	16.6 K to 14.8 K (-10.86 %)
Jun 29 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.55	4,600	20,923	16,581	21.2 K to 16.6 K (-21.72 %)
Jun 29 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.64	1,500	6,954	21,181	22.7 K to 21.2 K (-6.61 %)
Jun 25 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.69	600	2,814	22,681	23.3 K to 22.7 K (-2.58 %)
Jun 25 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.59	500	2,295	23,281	23.8 K to 23.3 K (-2.10 %)
Jun 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.65	1,200	5,580	23,781	25 K to 23.8 K (-4.80 %)
Jun 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.74	1,700	8,058	24,981	26.7 K to 25 K (-6.37 %)
Jun 19 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.60	1,400	6,440	26,681	28.1 K to 26.7 K (-4.99 %)
Jun 19 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.76	1,201	5,717	28,081	29.3 K to 28.1 K (-4.10 %)
Jun 17 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.78	400	1,912	29,282	29.7 K to 29.3 K (-1.35 %)
Jun 17 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.72	1,200	5,660	29,682	30.9 K to 29.7 K (-3.89 %)
Jun 15 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.96	2,500	12,406	30,882	33.4 K to 30.9 K (-7.49 %)
Jun 15 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.13	1,100	5,647	33,382	34.5 K to 33.4 K (-3.19 %)
Jun 11 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.02	1,500	7,529	34,482	36 K to 34.5 K (-4.17 %)
Jun 11 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.96	3,700	18,355	35,982	39.7 K to 36 K (-9.32 %)
Jun 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.04	4,000	20,144	39,682	43.7 K to 39.7 K (-9.16 %)
Jun 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.92	800	3,935	43,682	44.5 K to 43.7 K (-1.80 %)
Jun 05 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.94	2,600	12,848	44,482	47.1 K to 44.5 K (-5.52 %)
Jun 05 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.11	2,400	12,269	47,082	49.5 K to 47.1 K (-4.85 %)
Jun 03 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.19	6,084	31,560	49,482	55.6 K to 49.5 K (-10.95 %)
Jun 03 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.04	7,000	35,308	55,566	62.6 K to 55.6 K (-11.19 %)
Jun 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.56	2,300	12,790	62,566	64.9 K to 62.6 K (-3.55 %)
Jun 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.92	1,700	10,057	64,866	66.6 K to 64.9 K (-2.55 %)
May 28 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	6.00	4,800	28,803	66,566	71.4 K to 66.6 K (-6.73 %)
May 13 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.93	700	3,450	71,366	72.1 K to 71.4 K (-0.97 %)
May 11 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.82	1,743	8,402	72,066	73.8 K to 72.1 K (-2.36 %)
May 11 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.59	3,513	16,126	73,809	77.3 K to 73.8 K (-4.54 %)
May 07 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.42	4,051	17,893	77,322	81.4 K to 77.3 K (-4.98 %)
May 07 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.18	5,500	23,016	81,373	86.9 K to 81.4 K (-6.33 %)
May 05 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.86	2,300	11,178	86,873	89.2 K to 86.9 K (-2.58 %)
May 05 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.74	2,800	13,279	89,173	92 K to 89.2 K (-3.04 %)
May 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.90	5,500	26,968	91,973	97.5 K to 92 K (-5.64 %)
May 01 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.54	1,700	7,718	97,473	99.2 K to 97.5 K (-1.71 %)
Apr 29 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.66	1,200	5,587	99,173	100.4 K to 99.2 K (-1.20 %)
Apr 29 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.75	1,700	8,072	100,373	102.1 K to 100.4 K (-1.67 %)
Apr 27 2009	GALE	Galena Biopharma, ...	Chin Richard	Director	Option Exercise	A	4.60	50,000	230,000	50,000
Apr 27 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.87	2,000	9,733	102,073	104.1 K to 102.1 K (-1.92 %)
Apr 27 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.61	2,800	12,919	104,073	106.9 K to 104.1 K (-2.62 %)
Apr 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.82	1,000	4,816	106,873	107.9 K to 106.9 K (-0.93 %)
Apr 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.77	1,900	9,070	107,873	109.8 K to 107.9 K (-1.73 %)
Apr 21 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.84	300	1,452	109,773	110.1 K to 109.8 K (-0.27 %)
Apr 21 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.72	3,100	14,646	110,073	113.2 K to 110.1 K (-2.74 %)
Apr 17 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.79	2,900	13,883	113,173	116.1 K to 113.2 K (-2.50 %)
Apr 17 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.80	2,400	11,528	116,073	118.5 K to 116.1 K (-2.03 %)
Apr 15 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.96	6,300	31,258	118,473	124.8 K to 118.5 K (-5.05 %)
Apr 15 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.90	1,700	8,329	124,773	126.5 K to 124.8 K (-1.34 %)
Apr 13 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.92	1,200	5,898	126,473	127.7 K to 126.5 K (-0.94 %)
Apr 13 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.80	2,400	11,519	127,673	130.1 K to 127.7 K (-1.85 %)
Apr 08 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.51	800	3,605	130,073	130.9 K to 130.1 K (-0.61 %)
Apr 08 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.69	2,409	11,298	130,873	133.3 K to 130.9 K (-1.81 %)
Apr 06 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.89	1,400	6,849	133,282	134.7 K to 133.3 K (-1.04 %)
Apr 06 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.72	3,100	14,641	134,682	137.8 K to 134.7 K (-2.25 %)
Apr 02 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.80	2,610	12,538	137,782	140.4 K to 137.8 K (-1.86 %)
Apr 02 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.40	6,033	32,594	140,392	146.4 K to 140.4 K (-4.12 %)
Mar 31 2009	GALE	Galena Biopharma, ...	Varanasi Ramani	VP, Business Develo ...	Option Exercise	A	4.98	85,240	424,495	100,000
Mar 31 2009	GALE	Galena Biopharma, ...	Varanasi Ramani	VP, Business Develo ...	Option Exercise	A	4.98	14,760	73,505	14,760
Mar 31 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.00	1,100	5,496	147,325	148.4 K to 147.3 K (-0.74 %)
Mar 31 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	5.16	600	3,094	148,425	149 K to 148.4 K (-0.40 %)
Mar 31 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.64	4,209	19,520	149,025	153.2 K to 149 K (-2.75 %)
Mar 31 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.33	900	2,996	146,425	147.3 K to 146.4 K (-0.61 %)
Mar 27 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.99	1,700	6,789	153,234	154.9 K to 153.2 K (-1.10 %)
Mar 27 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.85	1,500	5,769	154,934	156.4 K to 154.9 K (-0.96 %)
Mar 25 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.66	800	2,928	156,434	157.2 K to 156.4 K (-0.51 %)
Mar 25 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.84	5,447	20,915	157,234	162.7 K to 157.2 K (-3.35 %)
Mar 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.60	1,600	5,766	162,681	164.3 K to 162.7 K (-0.97 %)
Mar 23 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.45	2,000	6,900	164,281	166.3 K to 164.3 K (-1.20 %)
Mar 19 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.83	3,400	13,039	166,281	169.7 K to 166.3 K (-2.00 %)
Mar 19 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.51	2,600	9,136	169,681	172.3 K to 169.7 K (-1.51 %)
Mar 12 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.44	2,700	9,276	175,984	178.7 K to 176 K (-1.51 %)
Mar 12 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.17	7,400	23,423	178,684	186.1 K to 178.7 K (-3.98 %)
Mar 16 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.05	2,401	7,325	172,281	174.7 K to 172.3 K (-1.37 %)
Mar 16 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.34	1,300	4,341	174,684	176 K to 174.7 K (-0.74 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.56	1,500	5,339	193,984	195.5 K to 194 K (-0.77 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.64	2,900	10,550	195,484	198.4 K to 195.5 K (-1.46 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.76	4,700	17,665	198,384	203.1 K to 198.4 K (-2.31 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.05	1,300	5,262	203,084	204.4 K to 203.1 K (-0.64 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.25	400	1,699	204,384	204.8 K to 204.4 K (-0.20 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.25	1,800	7,644	204,784	206.6 K to 204.8 K (-0.87 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	4.40	3,000	13,212	206,584	209.6 K to 206.6 K (-1.43 %)
Mar 10 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	2.97	4,500	13,364	186,084	190.6 K to 186.1 K (-2.36 %)
Mar 10 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.32	1,300	4,310	190,584	191.9 K to 190.6 K (-0.68 %)
Mar 09 2009	GALE	Galena Biopharma, ...	KRIEGSMAN STEVEN A	Director	Sell	S	3.36	2,100	7,057	191,884	194 K to 191.9 K (-1.08 %)
Mar 09 2009	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Gift	G	0.00	4,000	0	6,000	10 K to 6 K (-40.00 %)

Page: < prev 1 2 3 4 next >